Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Scandinavian phase II trial of Alpharadin extended to U.K.

Sep. 2, 2004

IC-MedTech licenses Apatone

Sep. 2, 2004

New mitotic kinesin KSP inhibitors discovered by Merck researchers

Sep. 2, 2004

Takeda develops new metastin derivatives for preventing cancer metastasis

Sep. 2, 2004

Biovitrum acquires oncology project from Karolinska

Sep. 1, 2004

PEP-005 initiates human clinical trials

Sep. 1, 2004

Amgen claims CDK inhibitors and their use

Sep. 1, 2004

Modulators of PDE4, MMP and/or TNF-alpha discovered at Celgene

Sep. 1, 2004

New modulators of chemokine CCXCKR2 receptors and their use in cancer therapy

Sep. 1, 2004

Orphan drug designation for AGRO-100

Sep. 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...